The time course of cardioprotection induced by GR79236, a selective adenosine A1-receptor agonist, in myocardial ischaemia-reperfusion injury in the pig

Journal of Cardiovascular Pharmacology
J B LouttitG M Drew


The cardioprotective effects of the selective adenosine A1-receptor agonist, GR79236 (N-[(1S, trans)-2-hydroxycyclopentyl]adenosine), were examined in a porcine model of myocardial ischaemia-reperfusion injury. When pigs were subjected to a 50-min coronary artery occlusion followed by 3-h reperfusion, GR79236 (10 nmol/kg, i.v.) significantly reduced infarct size whether given 10 min before the onset of ischaemia or reperfusion. This effect was independent of the bradycardia induced by GR79236, as it was also observed in animals in which heart rate was maintained by electrical pacing. However, GR79236 administered 10 min after reperfusion did not reduce infarct size. GR79236 had no effect on the incidence or outcome of ventricular dysrhythmias in this pig model of infarction. Similarly, ischaemic preconditioning (IPC, 2 x 10-min ischaemia and 10-min reperfusion) significantly reduced infarct size. The selective adenosine A1-receptor antagonist, 8-cyclopentyl-1,3-dipropylxanthine (DPCPX; 3.3 micromol/kg, i.v.), abolished the haemodynamic and cardioprotective effects of GR79236 and the cardioprotective effects of IPC in anaesthetised pigs. In conclusion, GR79236 exerted a marked cardioprotective effect in a porcine model of myocar...Continue Reading


Jul 1, 1973·The Journal of Clinical Investigation·J K Kjekshus, O D Mjos
Jul 1, 1994·Cardiovascular Research·G L ChienD M van Winkle
Jan 1, 1994·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·A M AlkhulaifiW B Pugsley
Apr 1, 1993·Cardiovascular Research·C S Lawson, J M Downey
Aug 1, 1993·Circulation·R Zucchi
Jul 1, 1993·British Journal of Pharmacology·M F GurdenC J Vardey
May 1, 1993·The American Journal of Physiology·P KaoutzaniJ L Madara
Jan 1, 1993·Cardiovascular Research·J M DowneyJ D Thornton


Jul 7, 2007·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Øyvind JakobsenDag G Sørlie
Feb 12, 2002·Bioorganic & Medicinal Chemistry·Sally A HutchinsonPeter J Scammells
Jun 26, 2009·Antioxidants & Redox Signaling·Melissa E ReicheltJohn P Headrick
Oct 2, 2009·Clinical and Experimental Pharmacology & Physiology·Fei XiangQiong Zhang
Oct 20, 2005·Cephalalgia : an International Journal of Headache·U ArulmaniP R Saxena
Apr 4, 2013·The American Journal of Chinese Medicine·Wei-Tien ChangZuo-Hui Shao
Jul 12, 2011·American Journal of Physiology. Heart and Circulatory Physiology·Enbo ZhanRobert D Lasley
Sep 21, 2010·American Journal of Physiology. Heart and Circulatory Physiology·Anna R BusijaHemal H Patel
Jun 15, 2013·Pharmacology & Therapeutics·John P HeadrickJason Peart
Sep 19, 2007·Expert Opinion on Emerging Drugs·Eric R Gross, Garrett J Gross
Apr 29, 2014·The Journal of Pharmacy and Pharmacology·Sophia-Iris BibliIoanna Andreadou
Dec 26, 2008·Current Opinion in Pharmacology·Dwaine S Burley, Gary F Baxter
Nov 26, 2010·Biochimica Et Biophysica Acta·John P HeadrickLuke J Haseler
Jul 24, 2004·American Journal of Physiology. Heart and Circulatory Physiology·Gentian KristoRobert D Lasley
May 19, 2006·The Journal of Biological Chemistry·Andrew K SnabaitisMetin Avkiran
Apr 10, 2007·American Journal of Physiology. Heart and Circulatory Physiology·Sandra CappelloMaria Carmela Cerra
Aug 23, 2011·American Journal of Physiology. Heart and Circulatory Physiology·Shoji SanadaMasafumi Kitakaze
Feb 28, 2002·The Journal of Pharmacology and Experimental Therapeutics·Arnaud ScherpereelVladimir R Muzykantov
May 23, 2002·Brain : a Journal of Neurology·P J GoadsbyH E Connor
Oct 17, 2003·American Journal of Physiology. Heart and Circulatory Physiology·John P HeadrickKevin J Ashton
Feb 1, 2002·American Journal of Physiology. Heart and Circulatory Physiology·John P Headrick
Feb 22, 2011·Journal of Cardiovascular Pharmacology and Therapeutics·Victoria J McIntosh, Robert D Lasley
Oct 25, 2000·American Journal of Physiology. Heart and Circulatory Physiology·J Peart, John P Headrick
Oct 22, 2002·American Journal of Physiology. Heart and Circulatory Physiology·Jason PeartJohn P Headrick
Dec 10, 2003·Expert Opinion on Emerging Drugs·Luo YanChrista E Müller

Related Concepts

PD 116948
N-((1S, trans)-2-hydroxycyclopentyl)adenosine
Anesthesia Procedures
Diastolic Blood Pressure
Coronary Heart Disease
Pulse Rate
Myocardial Infarction
Family suidae

Related Feeds


Bradyarrhythmias are slow heart rates. Symptoms may include syncope, dizziness, fatigure, shortness of breath, and chest pains. Find the latest research on bradyarrhythmias here.


Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.


Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.